Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection.
Lee, H; Kim, J; Kang, YA; Kim, DR; Sim, B; ZELMER, A; FLETCHER, HA; DOCKRELL, HM; SMITH, SG; Cho, S-N;
2019
Frontiers in Immunology, (2019).10 APR 10.3389/fimmu.2019.00896.
Lessons learnt conducting minimally invasive autopsies in private mortuaries as part of HIV and tuberculosis research in South Africa.
KARAT, AS; Omar, T; Tlali, M; Charalambous, S; Chihota, VN; Churchyard, GJ; FIELDING, KL; Martinson, NA; McCarthy, KM; GRANT, AD;
2019
Public Health Action, (2019).9 4 10.5588/pha.19.0032.
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
Penn-Nicholson, A; Hraha, T; Thompson, EG; Sterling, D; Mbandi, SK; Wall, KM; Fisher, M; Suliman, S; Shankar, S; Hanekom, WA; Janjic, N; Hatherill, M; Kaufmann, SH E; SUTHERLAND, J; Walzl, G; De Groote, MA; Ochsner, U; Zak, DE; Scriba, TJ; ACS and GC6–74 cohort study groups,;
2019
PLoS medicine, (2019).16 4 10.1371/journal.pmed.1002781.
The burden of non-TB lung disease presenting to TB clinics in The Gambia: preliminary data in the Xpert® MTB/Rif era.
Jayasooriya, S; Jobe, A; Badjie, S; Owolabi, O; Rachow, A; SUTHERLAND, J; KAMPMANN, B;
2019
PUBLIC HEALTH ACTION, (2019).9 4 10.5588/pha.19.0046.
Diabetes Mellitus Among Pulmonary Tuberculosis Patients From 4 Tuberculosis-endemic Countries: The TANDEM Study.
UGARTE-GIL, C; Alisjahbana, B; Ronacher, K; Riza, AL; Koesoemadinata, RC; Malherbe, ST; Cioboata, R; Llontop, JC; Kleynhans, L; Lopez, S; Santoso, P; Marius, C; Villaizan, K; Ruslami, R; Walzl, G; Panduru, NM; DOCKRELL, HM; Hill, PC; Mc Allister, S; Pearson, F; MOORE, DA J; Critchley, JA; Van Crevel, R;
2019
Clinical infectious diseases, (2019).70 5 10.1093/cid/ciz284.
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data.
PEDRAZZOLI, D; KRANZER, K; Thomas, HL; Lalor, MK;
2019
ERJ Open Res, (2019).5 4 10.1183/23120541.00125-2019.
Improving the quality of modelling evidence used for tuberculosis policy evaluation.
Menzies, NA; MCQUAID, CF; Gomez, GB; Siroka, A; Glaziou, P; Floyd, K; WHITE, RG; HOUBEN, RM G J;
2019
The international journal of tuberculosis and lung disease, (2019).23 4 10.5588/ijtld.18.0660.
Diabetes is associated with genotypically drug-resistant tuberculosis.
Ruesen, C; Chaidir, L; Ugarte-Gil, C; Van Ingen, J; Critchley, JA; Hill, PC; Ruslami, R; Santoso, P; Huynen, MA; DOCKRELL, HM; MOORE, DA J; Alisjahbana, B; Van Crevel, R;
2019
The European respiratory journal, (2019).55 3 10.1183/13993003.01891-2019.
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome.
Duffy, FJ; Weiner, J; Hansen, S; Tabb, DL; Suliman, S; Thompson, E; Maertzdorf, J; Shankar, S; Tromp, G; Parida, S; Dover, D; Axthelm, MK; SUTHERLAND, JS; DOCKRELL, HM; Ottenhoff, TH M; Scriba, TJ; Picker, LJ; Walzl, G; Kaufmann, SH E; Zak, DE; GC6-74 Consortium,;
2019
FRONTIERS IN IMMUNOLOGY, (2019).10 MAR 10.3389/fimmu.2019.00527.
Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts.
Gebremicael, G; Kassa, D; Alemayehu, Y; Gebreegziaxier, A; Kassahun, Y; Van Baarle, D; H M Ottenhoff, T; M Cliff, J; C Haks, M;
2019
PloS one, (2019).14 12 10.1371/journal.pone.0226137.